| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |